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in clinical populations. However, it cannot replace inter-
view based diagnoses, nor is it adequate to use just one 
informant.
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Introduction
Anxiety disorders are prevalent paediatric mental disorders 
[1, 2]. In the short-term they are stable [3], and in the long-
term they show both homo-typic [4] and hetero-typic con-
tinuity [5]. In the latter respect, childhood and adolescent 
anxiety disorders confer a higher risk of both depression 
and somatic illness, but also of future drug use [5]. Further-
more, anxiety disorders have a negative impact on various 
domains of functioning, e.g. at school, in social life, and in 
family relations [6].
Moreover, many types of burdens are associated with 
anxiety disorders, including increased costs associated with 
the illness both due to the child staying away from school 
and due to parents’ leave from work [7]. Some of these 
effects are found even in long-term follow-up in adulthood, 
e.g. lower income, and difficulties in social relationships 
[5].
Despite these disorders’ high prevalence in the gen-
eral population, they are less common in child psychiatric 
care than their proportion in the general population would 
imply. Referrals to the specialized child- and adolescent 
psychiatry (CAP) services are greater for externalizing and 
disruptive disorders than for anxiety disorders. Gren Lan-
dell [8] found, for example, that just one out of five chil-
dren with social anxiety disorder in a high school study had 
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a CAP contact and Hansen [9] noted in a CAP outpatient 
sample that about half of those with a KSADS anxiety 
disorder at intake had not been referred because of anxi-
ety (see as well [10, 11]). Similarly, Heyman [12] found 
in an epidemiological study 25 children with OCD (0.25% 
of all children 6–17 years of age), and only three of them 
were known within the specialized CAP services, although 
a good third had consulted their general practitioner. Thus, 
there is a need for better screens for anxiety symptoms to 
be used in primary care and in the school health care.
Another problem is that children with anxiety disor-
ders do not seek help themselves like adults do. They are 
dependent on parents or teachers to recognize the symp-
toms and the need. Thus, there is a question of how to eval-
uate and compare the information an informant provides, 
i.e., which information, when applied in a scale, is best fit-
ted for aiding the diagnostic process [13]. There are several 
challenges associated with such an evaluation. With regard 
to parental reports of the symptoms of anxiety disorders, 
those that are overt, i.e. the disorders’ behavioural manifes-
tations, can be observed by the parent and may be easier 
to rate [14]. In these respects, the challenge concerns the 
interpretation of at least some of these overt behaviours. 
The interpretation is dependent on an understanding of the 
motivation underlying a behaviour or an adequate attribu-
tion of the cause of a behaviour [14]: is a refusal to go to 
school due to anxiety and an avoidance, or an expression of 
oppositionality with a wish to stay home and, for example, 
do more pleasurable activities? Thus, the level of parental 
insight into the child’s thoughts and feelings are crucial, 
and this is even more important about symptoms that are 
covert. They need to be reported to, or told the parent, and 
then translated to the items in the parent scale.
Children are commonly regarded as the best informant 
on subjective aspects of the disorder [15]. However, the 
“mapping” of these symptoms, i.e., reported by the child on 
a child scale is not without problems. In younger children 
or developmentally delayed or disordered children, a lack 
of introspective capacities and language skills may compro-
mise the reliability of these assessments. Moreover, chil-
dren may be less exact with describing impairment, dura-
tion, and intensity/severity.
The use of multiple informants, including both a chil-
dren’s and a parental symptom assessment have, however, 
but a low to moderate agreement [15, 16]. Thus, we are 
posed with the problems on how to combine the informa-
tion. In general, children tend to report more severe anxiety 
levels than parents do [15, 17].
Theses discrepancies in self- and parental reports makes 
it important to evaluate the information from different 
informants on a disorder specific level as the disorders 
vary with regard to how much the subjective perspective is 
central, and to which extent behavioural manifestations are 
core features.
Several self- and parent rating scales for anxiety symp-
toms have been constructed, and need to be adjusted to the 
changing perspectives as the diagnostic systems evolve. 
Recently, Muris and an expert group published an anxiety 
scale developed for the DSM-5 [18–20]. The Screen for 
Child Anxiety Related Emotional Disorders which is evalu-
ated in the paper and that was published by Birmaher [21] 
in 1997 covering the classical anxiety disorders (Separation 
anxiety, Social Anxiety and GAD) as well as panic disorder 
and school phobia was developed for the DSM IV [22]. Its 
psychometric properties were found to be good as well in a 
replication study [23] (see also [2, 3, 24]). Muris [25, 26] 
added some additional items to screen for OCD, specific 
Phobias (SP) and acute/post-traumatic stress disorder (A/
PTSD) as well. The revised scale is called the SCARED-R 
and its reliability and discriminant validity was studied fur-
ther in a clinical sample [27]. Muris [27] found a satisfac-
tory discriminant validity both in between the anxiety- and 
other disorders as well as within the group of anxiety disor-
ders itself. He noted that the SCARED-R had a reasonable 
capacity to predict specific anxiety disorders. No normative 
SCARED or SCARED-R data have been published in Swe-
den. However, in Norway (with a culture close to Sweden) 
Leikanger [2, 3] used the original SCARED in a sizeable 
sample of adolescents and has published normative data, as 
well as data on symptom change across 1 year.
The SCARED-R was translated into Swedish in 2008 
for use in a treatment project in paediatric OCD [28]. In 
the current paper, the utility of the Swedish SCARED/
SCARED-R is examined in a clinical diagnostic study [29] 
and psychometric data are published for the first time. In 
addition, the diagnostic accuracy is improved as we use 
KSADS diagnoses improved on through a LEAD process 
(see below) to validate the SCARED-R and its sub-scales. 
The advantage with the LEAD process is that additional 
information that may not be divulged in an interview set-
ting may come to the foreground as the work-up and the 
treatment unfolds. Moreover, the level of impairment that 
each disorder entails is assessed not only at the intake 
assessments, but is supplemented through both structured 
and more informal contacts with the school that the LEAD 
procedure may consider.
Aims
To recommend cut-off scores for the SCARED-R based 
on ROC curves for each scale/sub-scale, and to investi-
gate their usefulness in a psychiatric outpatient population 
based on the psychometric properties. The SCARED-Rs 
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In all we included 307 CAP outpatients, who consecutively 
(from January 2010 to March 2013) sought treatment at 
four different CAP clinics in southern Sweden, in the study. 
The clinics were the only provider of specialist level care 
and were situated in average level socio-economic areas for 
Sweden. Exclusion criterion was the need of interpretation 
for parents or patient. Forty cases were discarded due to 
protocol violations (one clinician used leading questions or 
did not ask both parent and child questions about all symp-
tom areas) or failure of the diagnostician to report data. 
Another 28 cases were withdrawn due to insufficient addi-
tional information in the medical records up until 6 months 
from intake, a pre-requisite for an adequate LEAD proce-
dure. Data from the remaining n = 239 cases are reported. 
Mean age of the 239 participants was 12.1 (sd. 3.1, range 
6.1–17.8) years old. The observation time that had yielded 
new information was 1.2 (sd. 0.6) years with a range 
0.1–3.1 years. The proportion of children 6–12 years was 
n = 138 (57, 7%). There were slightly more boys (n = 131, 
54.8%) than girls included and boys were slightly younger 
than girls (11.9 vs. 12.4 years, p = .007). Almost all chil-
dren had clinically significant disorders, with current Chil-
dren’s Global Assessment Scale scores (CGAS) for boys 
just below 50 (m = 48.0, SD = 0.46) and girls 50 (m = 50.0, 
SD = 0.56). No one had CGAS scores in the non-clinical 
range of 70 or above.
Further, out of the 239 patients, a SCARED self-rating 
scale was filled in by 204 patients (boys n = 112/girls n = 92 
respectively) and the corresponding parent-rating scale was 
filled in by 228 parents (boys n = 122/girls n = 106). Hence, 
numbers will vary somewhat across analyses.
Measures and Procedures
A comprehensive description of measures and procedures 
can be found in a previous report on the KSADS by Jarbin 
[30]. Shortly, the semi-structured interview, the the Schedule 
for Affective Disorders and Schizophrenia for School-Age 
Children- Present and Lifetime Version (K-SADS-PL) was 
used by resident MDs (either CAP specialists or in training 
to become CAP specialists) following a training program (see 
[30]). The KSADS interviews with both parents and patients 
yielded DSM IV diagnoses which were then further evalu-
ated using a “Longitudinal Expert All Data” (LEAD) process 
commonly viewed as the best proxy to a “gold standard” that 
can be used to evaluate semi-structured interviews. Through 
the LEAD process, all information brought in through diag-
nostic procedures, the level of impairment, and the outcome 
of treatment across a suitable time period is used [31–33] for 
the final LEAD diagnosis or diagnoses (see [31] for a detailed 
description). To be eligible for LEAD, the record should 
cover at least 6 months of follow-up from the K-SADS-PL 
and include at least three further visits or significant informa-
tion from a teacher or an assessment of a senior clinician. In 
the LEAD procedure, the judge has access to the K-SADS-PL 
interview as well as subsequent information from the medical 
records. All these data were retrieved using a structured form. 
Thus, the re-evaluation of the KSADS diagnoses was sys-
tematic and could include oral reports and report forms from 
teachers and other informants, psychological assessments and 
the outcome of pharmacological and psychological treatment. 
For further information about the reliability etc. of this pro-
cess, see Jarbin [30]. Furthermore, a research assistant asked 
the patient and parent to fill in the SCARED (as well as some 
other scales) during one visit.
Statistics
T-tests or χ2 tests were conducted to examine gender dif-
ferences, differences between diagnoses etc. Receiver 
operating characteristics (ROC) analyses were conducted 
to examine the concurrent validity of the SCARED total 
score and subscales [34]. Generally, the area under the 
curve (AUC) is judged to represent low accuracy between 
0.50 and 0.70, moderate accuracy between 0.70 and 0.90 
and >0.90 high accuracy [35]. Agreement between LEAD 
diagnoses and cut-off for the SCARED scales and sub-
scales were studied using the Kappa statistic. Regarding 
Kappa values a common interpretation is that: Poor agree-
ment = Less than 0.20; Fair agreement = 0.20–0.40; Moder-
ate agreement = 0.40–0.60; Good agreement = 0.60–0.80; 
Very good agreement = 0.80–1.00. We also conducted 
series of logistic regression analysis: first, to evaluate the 
concurrent and discriminant validity of the SCARED 
subscales vis-à-vis all anxiety diagnoses; second, sequen-
tial logistic regression analyses were conducted to exam-
ine whether adding an informant (child or parent) would 
increase how accurately children with a specific anxiety 




Based on the LEAD procedure, patients displayed a psychi-
atric disorder pattern that is representative of that seen in 
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CAP-clinics (Table 1) with almost 1/3rd affective disorders, 
a good 1/3rd anxiety disorders and many with neuropsychi-
atric disorders (ADHD, tics/Tourette and Autism Spectrum 
Disorders) (69.3%). In the latter case gender differences 
were strongly evident for the most prevalent disorder [i.e. 
ADHD combined type 36.7% boys/17.9% girls χ2(2, 12.341 
p = .002)], more so than in depressive and anxiety disorders 
(apart from social phobia), where gender differences were 
quite small. As the number of patients that had specific 
anxiety disorders differed, some tests are at risk for type 
II errors. However, for most disorders, our study provides 
enough patients to study psychometric properties of the 
SCARED-R with sub-scales (Table 1).
Gender and Informant Differences
Girls scored higher than boys on the SCARED/SCARED-
R total scores self-ratings. Such gender differences were 
less and non-significant in parent ratings, in line with the 
small gender difference in the prevalence of “any anxiety 
Table 1  The frequency of 
psychiatric disorders in the 
outpatient sample
Gender differences: an.s.; bp < .001; cp = .031; di.e. ADHD, Autism Spectrum and tics/Tourette’s disorder; 
ei.e. oppositional-defiant disorder and conduct disorder
Psychiatric disorders Boys Girls Total
N % N % N %
Any affective disorder 40 26.7 40 34.2 80a 30.0
Anxiety disorder total 48 32.0 50 42.7 98a 36.7
Separation anxiety disorder (SAD) 12 8.0 10 8.5 22a 8.2
Social phobia (SoP) 6 4.0 13 11.1 19c 7.1
Generalized anxiety disorder (GAD) 6 4.0 10 8.5 16a 6.0
Anxiety NOS 7 4.7 6 5.1 13a 4.9
Obsessive-compulsive disorder 7 4.7 5 4.3 12a 4.5
Specific phobia (SP) 26 17.3 17 14.5 43a 16.1
Panic disorder (PD)/Agoraphobia 2 1.3 6 5.1 8a 3.0
Posttraumatic stress disorder 0 0 2 1.1 2a 0.7
Any neurodevelopmental  disorderd 117 78 68 58.1 185b 69.3
Any disruptive behavioural  disordere 57 38 36 30.8 93a 34.8%
Table 2  Means, standard deviations and independent t-test as per diagnostic group for self- respectively parent ratings separately for boys and 
girls
SCARED subscales: SAD Separation Anxiety Disorder, SoP Social phobia, GAD Generalized anxiety disorder, SchoP School phobia, OCD 
Obsessive-compulsive disorder, SP Specific phobia, PD Panic disorder, APTSD Acute or post-traumatic stress disorder
*p < .05; **p < .01; ***p < .001
Significant differences between child and parent report: a = p < .001; b = p < .01; c = p < .05
Child rating Parent rating





















SCARED total score (41 
items)
21.33 (12.73) 17.67 (11.99) 25.79 (12.22)c −4.774*** 16.09 (12.42) 15.46 (12.30) 16.83 (12.57)c −0.836
SCARED-R total score (69 
items)
35.16 (19.89) 29,24 (18,89)a 42.37 (18.75)c −4.956*** 23.19 (16.72) 22.21 (16,65)a 24.34 (16.81)c −0.966
SAD (8) 3.60 (2.95) 2.88 (2.68) 4.49 (3.03)c −4.034*** 2.94 (3,06) 2.71 (2.90) 3.21 (3.23)c −1.227
SoP (7) 5.10 (3.36) 4.61 (3.36)c 5.71 (3.27)c −2.352* 3,77 (4,03) 3.77 (4.01)c 3.77 (4.08)c 0.003
GAD (9) 5.51 (4.23) 4.29 (3.91) 7.00 (4.16)b −4.781*** 4.79 (4.15) 4.38 (4.05) 5.26 (4.24)b −1.611
SchoP (5) 2.29 (2.14) 1.93 (1.93) 2.74 (2.30) −2.737** 2.30 (2.29) 2,30 (2,36) 2.30 (2.21) 0.016
OCD (9) 5.21 (3.45) 4.83 (3.37)a 5.67 (3.51)c −1.745 2.32 (2.49) 2,41 (2,51)a 2.22 (2.48)c 0.587
SP (13) 6.64 (4.78) 5.22 (4.13) 8.37 (4.97)c −4.851*** 3.99 (3.74) 3.61 (3.62) 4.43 (3.85)c −1.674
PD (13) 4.82 (4.49) 3.96 (4.13) 5.86 (4.71)c −3.061** 2.30 (3.84) 2.30 (3.86) 2.30 (3,84)c −0.006
APTSD (4) 1.98 (2.24) 1.52 (2.06) 2.53 (2.33)c −3.300*** 0.79 (1.42) 0.73 (1.36) 0.86 (1.49)c −0.703
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disorder” (Table 2). This pattern, is evident as well at the 
level of specific anxiety diagnoses except OCD, where self- 
and parental ratings were comparable.
Thus, the moderate parent-child agreement (range about 
r = 0.5 for school phobia and panic disorder to r = 0.37 
for GAD, all p < .001) and the particularly low agreement 
we saw on the OCD-scale (r = 0.21, p = 0.004), may have 
different causes. It may be caused by girls’ elevated self-
ratings but also by boys’ low self-ratings when compared 
with parental ratings (Table 2). However, boys’ self-ratings 
varied, and were similar to parents’ ratings for some sub-
scales, and even significantly higher than their parents’ rat-
ings on two sub-scales (OCD and SoP) (Table 2).
Screening Efficiency
First, we conducted a series of ROC analyses to evaluate 
how efficiently the total scores and subscales would pre-
dict the presence of any anxiety disorder and specific ADs 
(See Table 3). All predictions were significant. The child-
reported total scores (SCARED and SCARED-R) predicted 
the presence of any AD with low accuracy and the parent-
reported total scores predicted the presence of any AD with 
moderate accuracy. The disorder-specific subscales pre-
dicted their corresponding disorder with low to moderate 
accuracy (Table 3).
Secondly, we selected the most efficient cut-offs to mini-
mize false-positive and false-negative equally by focusing 
on maximizing efficiency κ(0.5) [36], and evaluated the 
sensitivity and specificity of these cut-off scores (Table 3). 
In all instances, the Kappa [κ(0.5)] showed fair agreement 
between the total scores/subscales and their corresponding 
diagnosis except that the cut-off values for the GAD sub-
scale had poor agreement with the LEAD GAD diagnosis 
(Table 3).
Most SCARED/SCARED-R sub-scales for self-ratings 
showed adequate “Area Under the Curve” (AUC) in ROC 
analysis (Table 3), ranging from low accuracy for specific 
phobias (AUC = 0.61, p = 0 043) to a moderate, bordering 
on high, (AUC = 0.89, p < .001) for parental rating of social 
anxiety OCD (Table 3). Thus, most cut-off scores that are 
based on the ROC analyses (based on the point where both 
sensitivity and specificity are optimal) can be used with 
confidence, given that the purpose of its use is in line with 
the way we estimated it. The sensitivity ranges from the 
lowest (60%) for OCD to the highest (92%) for PD. The 
corresponding specificity ranged from the lowest (60%) for 
GAD to the highest (91%) for OCD.
The SCARED and SCARED-R total scores show cor-
responding adequate AUC levels, with cut-off yielding 
high sensitivity, low specificity but still fair kappa levels 
(Table 3).
Thirdly, we also conducted a series of logistic regres-
sion analyses to evaluate the concurrent and discriminant 
validity of each subscale, i.e. verifying whether only the 
corresponding subscale of the SCARED would be associ-
ated with particular LEAD diagnoses (Table 4). The Odds 
Ratios (OR), based on logistic regression, shows whether 
a SCARED/SCARED-R sub-scale relates to the LEAD 
anxiety diagnoses. It shows, for example that for every 
Table 3  Psychometric properties for the SCARED-R versus a LEAD diagnosis of any anxiety disorder and the specific anxiety disorders
AUC Area under the curve, SAD separation anxiety disorder, SP specific phobia, SoP social phobia, GAD generalized anxiety disorder, PD panic 
disorder, OCD obsessive-compulsive disorder, APTSD acute or post-traumatic stress disorder
SCARED scale/subscale -> LEAD Report AUC P Cut-off Sensitivity % Specificity % Kappa
SCARED total score → Any anxiety Child 0.66 <0.001 ≥15 84 43 0.23
Parent 0.72 <0.001 ≥14 68 61 0.27
SCARED-R total score → Any anxiety Child 0.65 <0.001 ≥25 84 43 0.23
Parent 0.72 <0.001 ≥34 43 89 0.34
SAD → SAD Child 0.76 <0.001 ≥5 78 70 0.21
Parent 0.84 <0.001 ≥5 79 80 0.32
SoP → SoP Child 0.85 <0.001 ≥8 77 80 0.29
Parent 0.89 <0.001 ≥9 75 88 0.39
GAD → GAD Child 0.71 0.008 ≥6 79 60 0.11
Parent 0.74 0.002 ≥8 56 80 0.17
OCD → OCD Child 0.84 <0.001 ≥10 60 91 0.31
Parent 0.84 <0.001 ≥9 46 97 0.42
SP → SP Child 0.61 0.043 ≥7 68 57 0.13
Parent 0.68 0.001 ≥5 63 70 0.21
PD → PD Child 0.84 <0.001 ≥6 92 69 0.18
Parent 0.88 <0.001 ≥4 83 83 0.28
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additional point scored on the child SAD scale or the parent 
SAD scale, the likelihood increases 1.42 (p = .001), respec-
tively 1.59 (p = .001) times, that a SAD diagnosis will be 
present. Likewise, the other SCARED scales (e.g. SoP and 
GAD) were significantly respectively tended to be related 
to their respective LEAD diagnoses, but the child SoP scale 
tended to predict a GAD as well but the GAD sub-scale 
did not predict SoP (see Table 4 for figures). On the other 
hand, the parent SoP sub-scale discriminated well against 
both SAD and GAD, but the parental GAD scale increased 
the likelihood of both a GAD (OR = 1,14, p = .055), a 
SoP (OR = 1,19, p = .026) and a PD diagnosis (OR = 1,34, 
p = .018) but decreased the likelihood of a SAD diagnosis 
(OR = .79, p = .013).
For the additional SCARED-R scales, the OCD scales 
worked best (OR = 1.39, p = 0 009) and (OR = 1.47, 
p = .006) respectively with limited overlap against other 
diagnoses. However, both the SP and PD scales were 
weaker predictors of their “own” diagnosis and related to 
one other diagnosis each OCD and SAD respectively.
Adding Parent Information to Child Information (and 
Vice Versa)
We also evaluated the possible benefit of adding the 
SCARED parent-report to the child-report (and vice versa) 
in predicting the presence of LEAD ADs, using a sequen-
tial logistic regression analysis, to evaluate whether the 
SCARED total score and subscales would predict the pres-
ence/absence of any anxiety disorder (SAD, SoP, GAD, 
OCD, SP and, PD). We entered the child-report first and 
then added the parent-report following which we started 
out with the parent-report first and then added the child-
report. Thus, the unique contribution of each informant to 
the other was evaluated.
Table 4  Convergent/divergent validity of the SCARED child- and parent report versus LEAD diagnoses using logistic regression where the 
Odds Ratio (OR) refers to the likelihood of a diagnosis for every additional score point on the scale/sub-scale
*Low SP score = more likelihood of LEAD SAD
SCARED-R LEAD diagnoses
SAD OR (95% 
CI) P
SP OR (95% CI) P SoP OR (95% CI) P PD OR (95% CI) P GAD OR (95% 
CI) P
OCD OR (95% CI) P
Child-report
χ2, P 20.066, p = .003 5.53 p = .478 33.067, p < .001 13.155, p = .041 19.271, p = .004 16.065, p = .013
SAD 1.50 (1.21, 
1.85) < 0.001
0.93 (0.78, 1.11) 
0.440
0.96 (0.76, 1.22) 
0.746
1.07 (0.76, 1.50) 
0.690
1.23 (0.98, 1.54) 
0.078
0.95 (0.71, 1.26) 
0.716
SP 0.92 (0.80, 1.05) 
0.228
1.10 (0.99, 1.23) 
0.075
0.93 (0.79, 1.09) 
0.347
0.97 (0.78, 1.19) 
0.753
0.96 (0.82, 1.11) 
0.551
1.09 (0.91, 1.30) 
0.336
SoP 1.07 (0.90, 1.28) 
0.439




1.05 (0.81, 1.35) 
0.731
1.17 (0.96, 1.43) 
0.111
0.98 (0.79, 1.21) 
0.844
PD 1.01 (0.85, 1.20) 
0.905
1.03 (0.91, 1.17) 
0.650
1.12 (0.95, 1.33) 
0.187
1.18 (0.95, 1.48) 
0.142
1.02 (0.86, 1.21) 
0.835
0.93 (0.76, 1.14) 
0.486
GAD 0.88 (0.72, 1.06) 
0.177
0.96 (0.84, 1.11) 
0.596
1.09 (0.92, 1.29) 
0.314
1.16 (0.89, 1.51) 
0.265
1.23 (1.02, 1.49) 
0.030
1.05 (0.84, 1.33) 
0.655
OCD 1.00 (0.81, 1.23) 
0.996
1.04 (0.89, 1.21) 
0.633
0.83 (0.66, 1.05) 
0.114
0.91 (0.66, 1.26) 
0.582
0.84 (0.66, 1.08) 
0.170
1.39 (1.08, 1.78) 
0.009
Parent-report
χ2, P 42.811, p < .001 11.268, p = .080 43.997, <0.001 19.027, p = .004 16.549, p = .011 24.060, p = .001
SAD 1.79 (1.40, 
2.28) < 0.001
0.96 (0.84, 1.11) 
0.610
0.78 (0.61, 1.00) 
0.054
1.06 (0.79, 1.43) 
0.688
1.01 (0.83, 1.22) 
0.959
0.86 (0.66, 1.11) 
0.237
SP 0.78 (0.62, 097) 
0.027*
1.13 (1.01, 1.26) 
0.027
1.11 (0.94, 1.32) 
0.224
1.00 (0.81, 1.24) 
0.987
1.06 (0.90, 1.24) 
0.497
1.14 (0.96, 1.35) 
0.134
SoP 1.11 (0.96, 1.29) 
0.172




0.89 (0.71, 1.13) 
0.340
1.12 (0.98, 1.29) 
0.092
0.89 (0.74, 1.08) 
0.247
PD 1.14 (0.94, 1.37) 
0.176
0.99 (0.88, 1.11) 
0.874
0.96 (0.83, 1.10) 
0.530
1.15 (0.98, 1.35) 
0.086
1.03 (0.90, 1.17) 
0.667
1.09 (0.93, 1.28) 
0.266
GAD 0.78 (0.62, 0.97) 
0.28*
1.01 (0.90, 1.12) 
0.919
1.21 (1.03, 1.43) 
0.022
1.32 (1.02, 1.71) 
0.038
1.18 (1.01, 1.37) 
0.035
1.02 (0.84, 1.23) 
0.861
OCD 0.90 (0.65, 1.26) 
0.544
1.00 (0.83, 1.21) 
0.975
0.97 (0.75, 1.24) 
0.776
1.05 (0.77, 1.43) 
0.767
0.88 (0.68, 1.13) 
0.308
1.47 (1.12, 1.94) 
0.006
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The final results of the logistic regression analyses 
are shown in Table 5. The goodness-of-fit in testing the 
prediction of anxiety disorders was good in all cases 
(Hosmer-Lemeshow p > .05). In single variable models, 
both the child- and parent-reports of the SCARED-R 
total score predicted the presence of any anxiety disorder, 
and ORs were (3.98, 95% CI 1.95, 8.11 and 5.79, 95% 
CI 2.82, 11.91 respectively) explaining  (R2) 0.11 and 
0.16 respectively proportion of the variation. However, in 
both instances we observed significant benefits of adding 
the parent-report to the child report (Δχ2Parent = 19.081, 
p < .001) respectively adding the child-report to the 
parent-report (Δχ2Child = 10.508, p < .001). In the final 
model both child- and parent-report each contributed sig-
nificantly to the prediction of any anxiety disorder (see 
Table 5 for OR and χ2).
For the SCARED total score both child-, and parent-
report predicted the presence of any anxiety disorder in a 
single-variable model (OR were 3.85, 95% CI 1.88, 7.85 
and 2.92, 95% CI 1.60, 5.32 respectively) with  R2 0.10 and 
0.09 respectively. In both instances the model improved by 
adding the other informant (Δχ2Parent = 8.212, p < .01 and 
Δχ2Child = 11.089, p < .001) (see Table 5 for OR and χ2).
For the SAD subscale both versions were significant in 
the single variable model (OR = 7.96, 95% CI 2.51, 25.26 
and OR = 15.59, 95% CI 4.82, 50.41) with  R2 0.16 and 0.27 
respectively. However, the model improved only by add-
ing parent-report to the child-report (Δχ2Parent = 14.407, 
p < .001) but not by adding the child-report to the parent-
report (Δχ2Child = 3.30) (see Table 5 for OR and χ2).
For the SoP subscales both child- and parent-report 
showed significant ORs in the single variable model (OR 
Table 5  Sequential logistic regression to test the effects of child and parent report on the SCARED for the prediction of any anxiety disorder or 
specific anxiety disorders
In the multivariate model, the contribution of the child to the parent report and vice versa are added to the values in the single report from 
the uni-variate analysis (e.g., parent OR = 4.89 are added to the child OR = 3.89). The Δ19.081 is the difference between the full model χ2 
35.624 − 16.543 etc
LEAD diagnosis SCARED
Scale—Informant
OR (95%) Wald Full model χ2 Full model adding 
an extra report χ2 a
R2
Any anxiety univariate models Revised total—child 3.98 (1.95, 8.11) 14.389*** 16.543*** 0.11
Revised total—parent 5.79 (2.82, 11.91) 22.844*** 25.116*** 0.16
Any anxiety multivariate model Revised total—child 3.23 (1.54, 6.79) 9.551** 35.624*** Δ10.508*** 0.22
Revised total—parent 4.89 (2.33, 10.25) 17.687*** 35.624*** Δ19.081***
Any anxiety
univariate model
Total score—child 3.85 (1.88, 7.85) 13.687*** 15.678*** 0.10
Total score—parent 2.92 (1.60, 5.32) 12.255*** 12.801*** 0.09
Any anxiety
Multivariate model
Total score—child 3.26 (1.57, 6.77) 10.048** 23.890*** Δ11.089*** 0.16
Total score—parent 2.45 (1.32, 4.56) 8.030** 23.890*** Δ8.212**
SAD univariate models SAD – child 7.96 (2.51, 25.26) 12.371*** 15.367*** 0.16
SAD—parent 15.59 (4.82, 50.41) 21.042*** 26.444*** 0.27
SAD
Multivariate model
SAD—child 3.18 (0.88, 11.54) 3.096 29.774*** Δ3.330 0.31
SAD—parent 9.49 (2.67, 33.82) 12.057*** 29.774*** Δ14.407***
SoP univariate models SoP—child 11.76 (3.59, 38.56) 16.537*** 19.787*** 0.22
SoP—parent 20.74 (6.17, 69.77) 23.997*** 28.608*** 0.31
SoP
Multivariate model
SoP—child 6.29 (1.74, 22.75) 7.868** 37.232*** Δ8.624** 0.40
SoP—parent 12.72 (3.56, 45.44) 15.314*** 37.232*** Δ17.445***
GAD
Univariate models
GAD—child 5.45 (1.47, 20.20) 6.435* 7.976** 0.10
GAD—parent 6.29 (1.99, 19.77) 9.854** 10.318*** 0.13
GAD
Multivariate model
GAD—child 3.98 (1.04, 15.32) 4.039* 15.043*** Δ4.725* 0.18
GAD—parent 4.77 (1.47, 15.49) 6.759** 15.043*** Δ7.067**
OCD
Univariate models
OCD—child 14.17 (3.65, 54.93) 14.698*** 14.118*** 0.21
OCD—parent 36.60 (7.96, 168.20) 21.406*** 19.201*** 0.28
OCD
Multivariate model
OCD—child 18.18 (3.21, 102.83) 10.758*** 31.140*** Δ11.938*** 0.44
OCD—parent 47.74 (7.07, 322.47) 15.734*** 31.140*** Δ17.021***
SP
Univariate models
SP—child 3.04 (1.31, 7.02) 6.743** 7.321** 0.06
SP—parent 3.96 (1.76, 8.93) 11.042*** 11.558*** 0.10
SP
Multivariate model
SP—child 2.17 (0.90, 5.26) 2.963 14.640*** Δ3.082 0.12
SP—parent 3.17 (1.36, 7.39) 7.085** 14.640*** Δ7.319**
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were 11.76, 95% CI 3.59, 38.56 and 20.74, 95% CI 6.17, 
69.77 respectively) with  R2 0.22 and 0.31 respectively. 
Both models improved by adding an extra informant 
(Δχ2Parent = 17.445, p < .001 and Δχ2Child = 8.624, p < .01) 
(see Table 5 for OR and χ2).
We found statistically significant associations between 
the GAD subscales and the presence of GAD both for the 
child-report and the parent report (OR were 5.45, 95% CI 
1.47, 20.20 and 6.29, 95% CI 1.99, 19.77 respectively) with 
 R2 0.10 and 0.13 respectively individually. Both models 
improved by adding an informant (Δχ2Parent = 7.067, p < .01 
and χ2Child = 4.725, p < .05) (see Table 5 for OR and χ2).
Next, we analysed whether the OCD subscales would 
predict the presence/absence of a LEAD OCD diagnosis, 
which both the child-report (OR = 14.17, 95% CI 3.65, 
54.93,  R2 = 0.21) and parent-report (OR = 36.60, 95% 
CI 7.96, 168.20,  R2 = 0.28) did. In addition, the model 
improved by adding an extra informant (Δχ2Parent = 17.021, 
p < .001 and Δχ2Child = 11.938, p < .001) (see Table  5 for 
OR and χ2).
We also assessed whether the SP subscales would pre-
dict the presence or absence of a LEAD SP diagnosis. 
Individually, both the child-report (OR = 3.04, 95% CI 
1.31, 7.02, R2 = 0.06) and the parent-report (OR = 3.96, 
95% CI 1.76, 8.93,  R2 = 0.10) had significant association 
with the SP diagnosis. We also observed a significantly 
improved model by adding the parent-report to the child-
report (Δχ2Parent = 7.319, p < .01). However, adding the 
child-report to the parent-report did not improve the overall 
model (Δχ2Child = 3.083, n.s.) (see Table 5 for OR and χ2).
Discussion
The study is the first to evaluate the utility of the SCARED-
R scale and sub-scales based on the psychometric proper-
ties versus the gold-standard called LEAD [31–33]. It can 
thus be expected to provide the most accurate assessment 
of its usefulness and validity of its predictions. The popula-
tion that we used was child-psychiatric outpatients having 
a level of co-morbidity that can be expected from a general 
clinical population (Table  1) [37]. Thus, the assessments 
include the various confounds that the clinician is con-
fronted with in the clinic.
First, the SCARED original scale (i.e. that published 
by Birmaher [21]) and which assesses the three “classi-
cal” child anxiety disorders (separation anxiety disorder, 
social anxiety disorder and generalized anxiety disorder), 
and panic disorder could be shown to be a valid measure 
with regard to each of these four diagnostic entities (kappa 
values against LEAD ranged from 0.11 to 0.21 for self-
ratings and from 0.17 to 0.39 for parental ratings). Moreo-
ver, the three classical anxiety disorders and panic disorder 
SCARED scales showed moderate AUC values. Gener-
ally, the area under the curve (AUC) is judged to represent 
low accuracy between 0.50 and 0.70, moderate accuracy 
between 0.70 and 0.90 and above 0.90 high accuracy [35].
The cut-off values for these scales rendered accept-
able sensitivity and specificity. However, there are caveats, 
mainly based on the limited agreement between the child 
and the parent (ranging from 0.37 to 0.48) and the poor 
agreement against LEAD for GAD (Table 3). Despite this, 
adding an informant is worthwhile and increases the diag-
nostic precision (Table 5).
Although, the gender differences may point to a gen-
eral bias for under-reporting symptoms in boys and over-
reporting symptoms in girls, parents’ ratings were not so 
far above boys’ self-ratings. Possibly, girls’ reports are the 
bigger problem, and one can speculate whether their scores 
reflect a different judgment of severity, or if the scale meas-
ures “en passant” other phenomena than just anxiety dis-
orders. Despite these caveats, we conclude that the three 
classical SCARED sub-scales show good psychometric 
properties in line with previous studies [15] and can be 
used with confidence using the cut-off values we provide 
(Table 3).
School phobia is not a DSM IV/5 diagnosis so that its 
psychometric properties cannot be studied versus an anxi-
ety specific LEAD diagnosis.
The situation with regard to the added subscales in the 
SCARED-R [27] is similar. Sub-scales for OCD and spe-
cific phobia were studied (as A/PTSD had only two cases 
the psychometric properties are not discussed). These 
sub-scales were valid measures regarding corresponding 
two diagnostic entities (kappa values against LEAD were 
respectively 0.13 and 0.31 for self-ratings and 0.42 and 
0.21 for parental ratings). Moreover, these scales showed 
moderate AUC values, and the cut-off values for these 
scales rendered acceptable sensitivity and specificity. How-
ever, there are caveats, mainly based on the limited agree-
ment between the child and the parent (ranging from 0.12 
to 0.47).
Moreover, the gender differences may point to a general 
bias for under-reporting symptoms in boys and over-report-
ing symptoms in girls. Despite these caveats, we conclude 
that the two added SCARED sub-scales show acceptable 
psychometric properties.
However, a clinician must consider for what purpose the 
scale is used. The cut-off values described for each scale 
or sub-scale are mathematical constructs rather than, for 
example a useful cut-off value for screening. Cut-off values 
in Table  3 are points on the ROC-curves where the most 
optimal compromise between sensitivity and specificity is 
obtained. In  situations when screening for anxiety disor-
ders in the clinic, it may be proper to use a lower cut-off 
score with a higher sensitivity with a concomitant lower 
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specificity. Thus, the purpose must dictate what cut-off 
score to use. Our data indicate that the SCARED-R is use-
ful as a screen for the classical anxiety disorders, but also 
for OCD, panic and specific phobias.
In primary/first line child psychiatric care, the two total 
scores may have some usefulness, e.g. screening for the 
level of anxiety without wishing to pinpoint specific diag-
noses. In such cases, child ratings with a sensitivity of 
about 80% may be preferable.
Despite the caveats described above, adding the parent 
as an informant, or vice versa is worthwhile and increases 
the diagnostic precision (Table 5), contrary to one previous 
report [15]. However, with regard to SCARED SP respec-
tively SCARED SAD only parent reports added to the child 
report, while the child report did not increase diagnostic 
precision to the parental report. In all other instances, both 
the child and the parent report added to the parent respec-
tively child report, thus increasing diagnostic precision.
Moreover, while using the SCARED-R, the clinician 
should keep in mind that the properties of this scale are 
related to the DSM IV anxiety disorders constructs [22], 
and that these properties may differ from those of DSM-5 
diagnoses in some ways.
Summary
Both parents and children provide unique information, con-
tributing in most diagnostic areas to a correct diagnosis. 
We urge clinicians to use information from both the child 
and the parent both when using a scale like the SCARED/
SCARED-R and when assessing within an un-structured 
clinical interview. In most cases, each provides unique 
information. However, at which items this contribution 
is most crucial is not known, but could be studied in this 
sample.
First, even if this is a sizable study, the number of par-
ticipants in some diagnostic groups were too small, i.e. 
we had only two patients diagnosed with a post-traumatic 
stress disorder. Moreover, just eight patients with panic 
disorder/agoraphobia increases the risk of error. The 12 
patients with OCD was as well rather few. However, for the 
major “classical” anxiety disorders numbers were clearly 
adequate so that the concurrent and discriminant validity of 
these measures can be viewed as established.
Secondly, LEAD diagnoses based on enhancing 
KSADS with systematic diagnosis related information up 
to 6 months from inclusion, is still at some risk for chance 
variation in the information that is available within the 
medical records. As the SCARED was not a base for the 
LEAD diagnoses, artificially elevated validity measures are 
excluded.
Thirdly, the data that our study provides needs to be 
seen within the context of a normative study, for example 
regarding gender differences. A Norwegian study, i.e. from 
a culture close to the Swedish culture, of the SCARED 
showed data that are compatible with our findings [2] and 
showed gender differences that were quite similar to our 
findings.
The SCARED/SCARED-R is generally a valid and reli-
able screening tool. Particularly the classical SCARED has 
good psychometric properties and can be used with con-
fidence. However, the added sub-scales (i.e., SCARED-
R) shows more disparate findings, The OCD scale shows 
mixed results regarding validity/screening efficiency, 
which, despite a limited patient base, was statistically sig-
nificant. Regarding the SP scale, the psychometrics were 
not as good, despite an adequate number of patients.
The cut-off scores we provide represent a compromise 
between sensitivity and specificity, optimizing both. How-
ever, if a particular use of the SCARED scale presupposes, 
for example, a higher sensitivity, so that a lower cut-off 
score is used, then unavoidably specificity will be lower 
than the figures we provide, and the statistical association 
with the diagnoses will be changed. In general, but less 
exactly, the figures for adding child to parent information 
and vice versa are applicable.
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